DCF Advisers, LLC
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1802493
MOUNT PLEASANT, SC
Position in TEVA
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$9,036,000
-$2,979,850 QoQ
Shares Held
300,000
-22.1% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
3.89%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Derivatives in TEVA
reported options exposure · as of Dec 31, 2025CallValue
$312,100
CallShares
10,000
PutValue
$3,042,975
PutShares
97,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026DCF Advisers, LLC holds $13,278,325 across 3 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (68.1% of the industry book) .
All Filings in TEVA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,036,000 | 300,000 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $3,042,975 | 97,500 | Put | Sole | 2026-02-11 | |
| 2025-12-31 | $312,100 | 10,000 | Call | Sole | 2026-02-11 | |
| 2025-12-31 | $12,015,850 | 385,000 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $7,427,540 | 367,700 | Shares | Sole | 2025-11-12 | |
| 2025-09-30 | $1,161,500 | 57,500 | Call | Sole | 2025-11-12 | |
| 2025-06-30 | $3,058,700 | 182,500 | Shares | Sole | 2025-08-12 | |
| 2025-06-30 | $125,700 | 7,500 | Call | Sole | 2025-08-12 | |
| 2025-03-31 | $115,275 | 7,500 | Call | Sole | 2025-05-09 | |
| 2025-03-31 | $2,628,270 | 171,000 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $330,600 | 15,000 | Call | Sole | 2025-02-11 | |
| 2024-12-31 | $3,250,900 | 147,500 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,036,260 | 113,000 | Shares | Sole | 2024-11-13 | |
| 2024-09-30 | $603,670 | 33,500 | Call | Sole | 2024-11-13 | |
| 2024-06-30 | $2,124,687 | 130,750 | Shares | Sole | 2024-08-12 | |
| 2024-06-30 | $243,750 | 15,000 | Call | Sole | 2024-08-12 | |
| 2024-03-31 | $1,199,350 | 85,000 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $317,475 | 22,500 | Call | Sole | 2024-05-15 | |
| 2023-12-31 | $407,160 | 39,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $453,900 | 44,500 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $293,670 | 39,000 | Shares | Sole | 2023-08-09 | |
| No filing history on record for this holder in this stock. | ||||||